ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Oruka Therapeutics Inc

Oruka Therapeutics Inc (ORKA)

11,44
-0,75
(-6,15%)
Fermé 28 Janvier 10:00PM
11,47
0,03
(0,26%)
Après les heures de négociation: 1:59AM

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
11,44
Prix Achat
10,11
Prix Vente
15,00
Volume échangé
219 566
11,32 Fourchette du Jour 12,27
11,47 Plage de 52 semaines 31,13
Cap du marché
Clôture Veille
12,19
Ouverture
12,16
Dernière Transaction
644
@
11.44
(priorref)
Dernière heure de transaction
Volume financier
US$ 2 556 191
VWAP
11,642
Volume moyen (3 m)
306 800
Actions en circulation
34 998 550
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-75,21
Bénéfice par action (BPA)
-0,15
Chiffre d'affairess
-
Bénéfice net
-5,34M

À propos de Oruka Therapeutics Inc

ARCA biopharma Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to the development and commercialization of targeted therapies for cardiovascular diseases. The company's product candidates are rNAPc2 as a potential treatment for COVID-19, the disease syndrome ... ARCA biopharma Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to the development and commercialization of targeted therapies for cardiovascular diseases. The company's product candidates are rNAPc2 as a potential treatment for COVID-19, the disease syndrome caused by the SARS-CoV-2 virus, and potentially other viral diseases and Gencaro for the treatment of atrial fibrillation, or AF, in patients with chronic heart failure, or HF. rNAPc2 targets COVID-19 patients with biomarker evidence of coagulopathy, while Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy. Show more

Secteur
In Vitro,in Vivo Diagnostics
Industrie
In Vitro,in Vivo Diagnostics
Site Web
Siège social
Wilmington, Delaware, USA
Fondé
-
Oruka Therapeutics Inc est coté dans le secteur In Vitro,in Vivo Diagnostics de la NASDAQ avec le ticker ORKA. Le dernier cours de clôture d'Oruka Therapeutics était de US$12,19. Au cours de la dernière année, les actions de Oruka Therapeutics ont été négociées dans une fourchette de prix de US$ 11,47 à US$ 31,13.

Oruka Therapeutics compte actuellement 34 998 550 actions en circulation. La capitalisation boursière d'Oruka Therapeutics est de US$426,63 million. Oruka Therapeutics a un ratio cours/bénéfice (ratio PE) de -75.21.

ORKA Dernières nouvelles

Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-001, its Novel Half-life Extended Anti-IL-23p19 Antibody

Pharmacokinetic and safety data from healthy volunteers anticipated in the second half of 2025 On track to initiate a proof-of-concept study in psoriasis in the second half of 2025, with initial...

Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI)

MENLO PARK, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a biotechnology company developing novel biologics designed to set a new standard for the...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-1.56-121313.6211.4745576512.69329215CS
4-7.52-39.662447257418.9621.31511.4732345315.13985668CS
12-16.12-58.490566037727.5628.2511.4730680019.81094894CS
26-14.06-55.13725490225.531.1311.4720428421.07868285CS
52-14.06-55.13725490225.531.1311.4720428421.07868285CS
156-14.06-55.13725490225.531.1311.4720428421.07868285CS
260-14.06-55.13725490225.531.1311.4720428421.07868285CS

ORKA - Frequently Asked Questions (FAQ)

What is the current Oruka Therapeutics share price?
The current share price of Oruka Therapeutics is US$ 11,44
How many Oruka Therapeutics shares are in issue?
Oruka Therapeutics has 34 998 550 shares in issue
What is the market cap of Oruka Therapeutics?
The market capitalisation of Oruka Therapeutics is USD 426,63M
What is the 1 year trading range for Oruka Therapeutics share price?
Oruka Therapeutics has traded in the range of US$ 11,47 to US$ 31,13 during the past year
What is the PE ratio of Oruka Therapeutics?
The price to earnings ratio of Oruka Therapeutics is -75,21
What is the reporting currency for Oruka Therapeutics?
Oruka Therapeutics reports financial results in USD
What is the latest annual profit for Oruka Therapeutics?
The latest annual profit of Oruka Therapeutics is USD -5,34M
What is the registered address of Oruka Therapeutics?
The registered address for Oruka Therapeutics is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Oruka Therapeutics website address?
The website address for Oruka Therapeutics is www.orukatx.com
Which industry sector does Oruka Therapeutics operate in?
Oruka Therapeutics operates in the IN VITRO,IN VIVO DIAGNOSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
JGAurora Mobile Ltd
US$ 14,56
(142,18%)
38,51M
AKROAkero Therapeutics Inc
US$ 51,77
(97,75%)
15,06M
ORKTOrangeKloud Technology Inc
US$ 1,30
(88,41%)
62,83M
HWHHWH International Inc
US$ 0,49
(70,32%)
393,88M
GITSGlobal Interactive Technologies Inc
US$ 3,0424
(56,34%)
4,71M
ALLKAllakos Inc
US$ 0,2402
(-80,15%)
51,22M
NXUNXU Inc
US$ 0,2513
(-59,20%)
14,06M
VERUVeru Inc
US$ 0,6351
(-47,51%)
43,51M
WOKWORK Medical Technology Group Ltd
US$ 2,53
(-47,51%)
862,6k
NBISNebius Group NV
US$ 26,08
(-37,44%)
43,58M
NVDANVIDIA Corporation
US$ 118,42
(-16,97%)
798,94M
HWHHWH International Inc
US$ 0,49
(70,32%)
393,88M
HOLOMicroCloud Hologram Inc
US$ 1,67
(7,74%)
201,58M
ONCOOnconetix Inc
US$ 0,66
(37,50%)
185M
RGTIRigetti Computing Inc
US$ 12,44
(-5,76%)
123,5M
Aucune Discussion Trouvée
Ajouter une Discussion